Patents by Inventor John L. Dillon

John L. Dillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6242614
    Abstract: A process for the synthesis of paclitaxel from 10-deacetylbaccatin-III which is protected at the 7-position with a dialkylalkoxysilyl protecting group having the formula —Si(R)2(OR′).
    Type: Grant
    Filed: May 25, 2000
    Date of Patent: June 5, 2001
    Assignee: Bristol-Myers Squibb Company
    Inventors: Purushotham Vemishetti, Francis S. Gibson, John L. Dillon
  • Patent number: 5025501
    Abstract: In order to maximize protection against bacteria, this medical garment includes a double front. The medical garment includes a sleeve portion having first and second main sleeves extending continuously from the neck opening to an outer edge thereof. A first body portion of the garment has a first front panel extending continuously from the neck portion downwardly to a first bottom edge thereof, and a rear panel extending from the neck opening to the first bottom. A second body portion is secured to the rear panel and has a second front panel overlying the first front panel to provide the aforementioned double-layered front form the garment. The second front panel runs continuously from the neck opening to a second bottom edge thereof which is not attached to the first front panel such that an open passageway is formed between the first and second front panels to provide an added protective air space layer.
    Type: Grant
    Filed: December 22, 1989
    Date of Patent: June 25, 1991
    Inventor: John L. Dillon
  • Patent number: 4800226
    Abstract: A novel dimethylsulfate quaternary salt process intermediate useful in the manufacture of the antiarrhythmic agent encainide.
    Type: Grant
    Filed: April 20, 1987
    Date of Patent: January 24, 1989
    Assignee: Bristol-Myers Company
    Inventors: John L. Dillon, Richard H. Spector
  • Patent number: 4675409
    Abstract: A new and novel process for the preparation of encainide (4-methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]-benzanilide) has been developed. The process utilizes .alpha.-picoline, O-nitrobenzaldehyde, and anisoyl chloride as starting materials.
    Type: Grant
    Filed: February 25, 1986
    Date of Patent: June 23, 1987
    Assignee: Bristol-Myers Company
    Inventors: John L. Dillon, Richard H. Spector